Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Calliditas Therapeutics | CALTX | Apr 30, 2024 | 110.00 | +2.90 |
Camurus | CAMX | Apr 30, 2024 | 498.20 | +0.36 |
Cantargia | CANTA | Apr 30, 2024 | 3.34 | -2.74 |
Cereno Scientific B | CRNOB | Apr 30, 2024 | 3.85 | -2.23 |
Chordate Medical Holding | CMH | Apr 30, 2024 | 0.06 | +6.32 |
Chosa Oncology AB | CHOSA | Apr 30, 2024 | 1.00 | -0.20 |
Cline Scientific B | CLINEB | Apr 30, 2024 | 0.14 | -14.89 |
Coegin Pharma | COEGIN | Apr 30, 2024 | 2.91 | -1.36 |
Combigene | COMBI | Apr 30, 2024 | 3.65 | -2.67 |
Corline Biomedical | CLBIO | Apr 30, 2024 | 10.55 | 0.00 |
Cyxone | CYXO | Apr 30, 2024 | 0.09 | -2.55 |
DexTech Medical | DEX | Apr 30, 2024 | 5.10 | +4.51 |
Diagonal Bio | DIABIO | Apr 30, 2024 | 0.08 | +0.67 |
Diamyd Medical B | DMYDB | Apr 30, 2024 | 10.68 | -2.91 |
Dicot | DICOT | Apr 30, 2024 | 0.25 | +4.83 |
Double Bond Pharmaceutical B | DBPB | Apr 30, 2024 | 0.63 | +1.62 |
Ectin Research | ECTINB | Apr 30, 2024 | 0.33 | -16.24 |
Egetis Therapeutics | EGTX | Apr 30, 2024 | 6.38 | +8.69 |
Elicera Therapeutics | ELIC | Apr 30, 2024 | 0.94 | +0.43 |
Ellen | ELN | Apr 30, 2024 | 1.23 | 0.00 |
Enorama Pharma | ERMA | Apr 30, 2024 | 2.80 | 0.00 |
Enzymatica | ENZY | Apr 30, 2024 | 3.03 | +4.12 |
EQL Pharma | EQL | Apr 30, 2024 | 43.40 | -0.23 |
Eurocine Vaccines | EUCI | Apr 30, 2024 | 0.03 | +8.86 |
ExpreS2ion Biotech Holding | EXPRS2 | Apr 30, 2024 | 2.54 | -2.12 |
Fluicell | FLUI | Apr 30, 2024 | 0.09 | -7.90 |
Gabather | GABA | Apr 30, 2024 | 2.00 | +0.76 |
Genovis | GENO | Apr 30, 2024 | 27.85 | -0.71 |
Glycorex Transplantati.. | GTABB | Apr 30, 2024 | 0.85 | -14.63 |
Guard Therapeutics International | GUARD | Apr 30, 2024 | 29.20 | -1.35 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.